Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164019 · ClinicalTrials.gov registry record · NA
A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur
A NA study of Proximal Femoral Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 6
- Study locations
NCT02164019 is a NA study of Proximal Femoral Metastases that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 73 participants. The trial reports 6 study locations across 3 states.
The verdict
NCT02164019, a NA study of Proximal Femoral Metastases, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are looking to see if differences exist (after surgery) in function, quality of life, pain control, and possible complications.
Conditions Studied
Interventions
- BEHAVIORAL questionnaires
- PROCEDURE long-stem cemented hemiarthroplasty (LSCH)
- PROCEDURE intramedullary nailing (IMN)
Study Locations (6)
New York
- Memorial Sloan Kettering Cancer Center 1275 York Avenue - New York
- University of Rochester Medical Center - Rochester
- SUNY Upstate Medical University - Syracuse
- Montefiore Medical Center - The Bronx
Michigan
- Spectrum Health Medical Group - Grand Rapids
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-06 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02164019
The ClinicalTrials.gov registry entry for NCT02164019 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Proximal Femoral Metastases appearing as the primary indexed condition, and to 3 interventions - of which questionnaires is the first listed.
NCT02164019 reports 6 study locations spanning 3 distinct geographic areas - top geographies include New York, Michigan, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02164019 about?
NCT02164019 is a clinical study titled "A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur". The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are loo...
What is the current status of trial NCT02164019?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 73 participants. The study started on 2014-06. Estimated completion is 2026-06.
What conditions does trial NCT02164019 study?
This clinical trial studies the following conditions: Proximal Femoral Metastases.
What interventions are being tested in trial NCT02164019?
The interventions under investigation include: questionnaires (BEHAVIORAL), long-stem cemented hemiarthroplasty (LSCH) (PROCEDURE), intramedullary nailing (IMN) (PROCEDURE).
Who is sponsoring clinical trial NCT02164019?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02164019 being conducted?
This trial has 6 study locations across Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.